X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
morpholines - administration & dosage (1701) 1701
humans (1255) 1255
male (954) 954
index medicus (887) 887
female (728) 728
animals (651) 651
thiophenes - administration & dosage (440) 440
administration, oral (436) 436
middle aged (434) 434
rivaroxaban (418) 418
morpholines - pharmacology (407) 407
adult (396) 396
morpholines - therapeutic use (396) 396
aged (352) 352
morpholines - adverse effects (351) 351
anticoagulants - administration & dosage (333) 333
dose-response relationship, drug (315) 315
pharmacology & pharmacy (313) 313
rats (299) 299
treatment outcome (286) 286
mice (235) 235
benzimidazoles - administration & dosage (219) 219
oncology (217) 217
dabigatran (208) 208
morpholines - pharmacokinetics (196) 196
pyrazoles - administration & dosage (191) 191
naphthalenes - administration & dosage (186) 186
time factors (185) 185
thiophenes - adverse effects (183) 183
anticoagulants - adverse effects (171) 171
prevention (169) 169
pyridones - administration & dosage (157) 157
neurosciences (156) 156
double-blind method (154) 154
beta-alanine - analogs & derivatives (150) 150
double-blind (150) 150
beta-alanine - administration & dosage (145) 145
drug administration schedule (136) 136
analysis (129) 129
anticoagulants (129) 129
venous thromboembolism (127) 127
cancer (122) 122
hematology (122) 122
atrial fibrillation - drug therapy (117) 117
chromones - administration & dosage (117) 117
drug therapy, combination (117) 117
thiophenes - therapeutic use (116) 116
rats, sprague-dawley (115) 115
factor xa inhibitors (113) 113
urea - analogs & derivatives (112) 112
pharmacokinetics (111) 111
medicine & public health (110) 110
atrial fibrillation (109) 109
benzoxazines - administration & dosage (109) 109
urea - administration & dosage (108) 108
antiemetics - administration & dosage (106) 106
anticoagulants - therapeutic use (105) 105
chemotherapy (105) 105
adolescent (104) 104
peripheral vascular disease (104) 104
aged, 80 and over (102) 102
warfarin (102) 102
cardiac & cardiovascular systems (101) 101
cell line, tumor (100) 100
stroke - prevention & control (100) 100
aprepitant (97) 97
disease models, animal (96) 96
risk factors (93) 93
naphthalenes - pharmacology (92) 92
drug therapy (91) 91
hemorrhage - chemically induced (90) 90
benzimidazoles - adverse effects (87) 87
abridged index medicus (84) 84
care and treatment (84) 84
young adult (84) 84
nausea - chemically induced (83) 83
therapy (83) 83
signal transduction - drug effects (81) 81
injections, intravenous (80) 80
psychiatry (80) 80
pyridines - administration & dosage (80) 80
vomiting - chemically induced (80) 80
atrial fibrillation - complications (79) 79
research (78) 78
adrenergic beta-antagonists - administration & dosage (77) 77
expression (77) 77
warfarin - administration & dosage (75) 75
activation (73) 73
drug synergism (73) 73
drug interactions (72) 72
nausea (72) 72
prospective studies (72) 72
rats, wistar (72) 72
safety (71) 71
article (70) 70
phosphatidylinositol 3-kinases - antagonists & inhibitors (70) 70
infusions, intravenous (69) 69
venous thromboembolism - prevention & control (69) 69
vomiting - prevention & control (69) 69
benzimidazoles - therapeutic use (68) 68
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1491) 1491
Japanese (57) 57
German (48) 48
Russian (40) 40
French (24) 24
Spanish (14) 14
Chinese (13) 13
Italian (5) 5
Polish (4) 4
Hungarian (3) 3
Portuguese (3) 3
Danish (2) 2
Dutch (2) 2
Swedish (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Czech (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 02/2016, Volume 6, Issue 2, pp. 202 - 216
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9791, pp. 595 - 605
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2014, Volume 12, Issue 3, pp. 320 - 328
Journal Article
CIRCULATION, ISSN 0009-7322, 01/2013, Volume 127, Issue 2, pp. 224 - 224
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article